LRIG1 inhibits hypoxia-induced vasculogenic mimicry formation via suppression of the EGFR/PI3K/AKT pathway and epithelial-to-mesenchymal transition in human glioma SHG-44 cells

Cell Stress and Chaperones

Volumn 20, Issue 4, 2015, Pages 631-641

  Zhang, Xi ^a   Song, Qian ^b   Wei, Chunyan ^a   Qu, Jianqiang ^a  

^a THE SECOND AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

EGFR AKT PI3K pathway; Epithelial mesenchymal transition; LRIG1; Vasculogenic mimicry

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; LEUCINE RICH REPEATS AND IMMUNOGLOBULIN LIKE DOMAINS 1; PEPTIDES AND PROTEINS; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; CADHERIN; LRIG1 PROTEIN, HUMAN; MEMBRANE PROTEIN; VIMENTIN;

ANGIOGENESIS; ARTICLE; CELL HYPOXIA; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; GLIOMA CELL; GLIOMA CELL LINE; HUMAN; HUMAN CELL; MOLECULAR MIMICRY; PRIORITY JOURNAL; RNA INTERFERENCE; SHG 44 CELL LINE; VASCULOGENIC MIMICRY; ANTAGONISTS AND INHIBITORS; CELL MOTION; GENETICS; GLIOMA; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

CADHERINS; CELL HYPOXIA; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; GLIOMA; HUMANS; MEMBRANE GLYCOPROTEINS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; VIMENTIN;

EID: 84930867357     PISSN: 13558145     EISSN: 14661268     Source Type: Journal    
DOI: 10.1007/s12192-015-0587-y     Document Type: Article

References (29)

1. Du J, Sun B, Zhao X et al (2014) Hypoxia promotes vasculogenic mimicry formation by inducing epithelial-mesenchymal transition in ovarian carcinoma. Gynecol Oncol 133(3):575–583
2. Fan YZ, Sun W (2010) Molecular regulation of vasculogenic mimicry in tumors and potential tumor-target therapy. World J Gastrointest Surg 2(4):117–127
3. Gotoh N (2009) Feedback inhibitors of the epidermal growth factor receptor signaling pathways. Int J Biochem Cell Biol 41(3):511–515
4. Guo D, Nilsson J, Haapasalo H et al (2006) Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors. Acta Neuropathol 111(3):238–246
5. Holmlund C, Haapasalo H, Yi W et al (2009) Cytoplasmic LRIG2 expression is associated with poor oligodendroglioma patient survival. Neuropathology 29(3):242–247
6. Huang M, Ke Y, Sun X et al (2014) Mammalian target of rapamycin signaling is involved in the vasculogenic mimicry of glioma via hypoxia-inducible factor-1alpha. Oncol Rep 32(5):1973–1980
7. Johansson M, Oudin A, Tiemann K et al (2013) The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status. Neuro Oncol 15(9):1200–1211
8. Kumar M, Nagpal R, Hemalatha R et al (2012) Targeted cancer therapies: the future of cancer treatment. Acta Biomed 83(3):220–233
9. Maniotis AJ, Folberg R, Hess A et al (1999) Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155(3):739–752
10. Misra RM, Bajaj MS, Kale VP (2012) Vasculogenic mimicry of HT1080 tumour cells in vivo: critical role of HIF-1alpha-neuropilin-1 axis. PLoS One 7(11):e50153
11. Mongiardi MP (2012) Angiogenesis and hypoxia in glioblastoma: a focus on cancer stem cells. CNS Neurol Disord Drug Targets 11(7):878–883
12. Omuro A, DeAngelis LM (2013) Glioblastoma and other malignant gliomas: a clinical review. JAMA 310(17):1842–1850
13. Paulis YW, Soetekouw PM, Verheul HM, Tjan-Heijnen VC, Griffioen AW (2010) Signalling pathways in vasculogenic mimicry. Biochim Biophys Acta 1806(1):18–28
14. Persano L, Rampazzo E, Basso G, Viola G (2013) Glioblastoma cancer stem cells: role of the microenvironment and therapeutic targeting. Biochem Pharmacol 85(5):612–622
15. Plate KH, Scholz A, Dumont DJ (2012) Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited. Acta Neuropathol 124(6):763–775
16. Seftor RE, Hess AR, Seftor EA et al (2012) Tumor cell vasculogenic mimicry: from controversy to therapeutic promise. Am J Pathol 181(4):1115–1125
17. Taylor TE, Furnari FB, Cavenee WK (2012) Targeting EGFR for treatment of glioblastoma: molecular basis to overcome resistance. Curr Cancer Drug Targets 12(3):197–209
18. Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ (2010) Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 60(3):166–193
19. Verhaak RG, Hoadley KA, Purdom E et al (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17(1):98–110
20. Wang SY, Yu L, Ling GQ et al (2012) Vasculogenic mimicry and its clinical significance in medulloblastoma. Cancer Biol Ther 13(5):341–348
21. Wang SY, Ke YQ, Lu GH et al (2013) Vasculogenic mimicry is a prognostic factor for postoperative survival in patients with glioblastoma. J Neurooncol 112(3):339–345
22. Wang W, Lin P, Sun B et al (2014) Epithelial-mesenchymal transition regulated by EphA2 contributes to vasculogenic mimicry formation of head and neck squamous cell carcinoma. Biomed Res Int 2014:803914
23. Xie R, Yang H, Xiao Q et al (2013) Downregulation of LRIG1 expression by RNA interference promotes the aggressive properties of glioma cells via EGFR/Akt/c-Myc activation. Oncol Rep 29(1):177–184
24. Xu G, Bai X, Wang M, Xie W, Li R, Li C (2013a) Characterization of glycolytic phenotype of SHG44 human glioma cells under hypoxic conditions and its association with cell proliferation and apoptosis. Nan Fang Yi Ke Da Xue Xue Bao 33(3):406–411
25. Xu P, Zhang A, Jiang R et al (2013b) The different role of Notch1 and Notch2 in astrocytic gliomas. PLoS One 8(1):e53654
26. Ye F, Gao Q, Cai MJ (2010) Therapeutic targeting of EGFR in malignant gliomas. Expert Opin Ther Targets 14(3):303–316
27. Zhang S, Zhang D, Sun B (2007) Vasculogenic mimicry: current status and future prospects. Cancer Lett 254(2):157–164
28. Zhou X, Hu Y, Dai L et al (2014) MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancer. PLoS One 9(5):e96718
29. Zuo JH, Zhu W, Li MY et al (2011) Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin. J Cell Biochem 112(9):2508–2517